FFCP PHASE1:Hg19::chr8:114747320..114747347,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=not supported | |||
|DPIdataset=robust | |||
|EntrezGene=NA | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript | |||
|HGNC=NA | |||
|TSSclassifier=not | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|coexpression_cluster_id=C215 | |||
|description=CAGE_peak_at_chr8:114747320..114747347,- | |||
|id=chr8:114747320..114747347,- | |||
|ontology_enrichment_celltype=CL:0000037!3.78e-15!172;CL:0000566!3.78e-15!172;CL:0000988!4.13e-14!182;CL:0002032!1.23e-12!165;CL:0000837!1.23e-12!165;CL:0000817!1.32e-10!3;CL:0000763!2.15e-10!112;CL:0000049!2.15e-10!112;CL:0002127!4.19e-09!1;CL:0000914!4.19e-09!1;CL:0000911!4.19e-09!1;CL:0000814!4.19e-09!1;CL:0002042!4.19e-09!1;CL:0002039!4.19e-09!1;CL:0002040!4.19e-09!1;CL:0002041!4.19e-09!1;CL:0000946!1.13e-08!1;CL:0000786!1.13e-08!1;CL:0000980!1.13e-08!1 | |||
|ontology_enrichment_celltype_v019=CL:0002127;2.62e-23;1!CL:0000911;2.62e-23;1!CL:0000814;2.62e-23;1 | |||
|ontology_enrichment_celltype_v019_2=CL:0002127,2.62e-23,1;CL:0000914,2.62e-23,1;CL:0000911,2.62e-23,1;CL:0000814,2.62e-23,1;CL:0002042,2.62e-23,1;CL:0002039,2.62e-23,1;CL:0002040,2.62e-23,1;CL:0002041,2.62e-23,1;CL:0000893,2.32e-12,2;CL:0002489,2.32e-12,2;CL:0000809,2.32e-12,2;CL:0000808,2.32e-12,2;CL:0000894,2.32e-12,2;CL:0000806,2.32e-12,2;CL:0000807,2.32e-12,2;CL:0000805,2.32e-12,2;CL:0002425,2.32e-12,2;CL:0000763,8.31e-10,108;CL:0000049,8.31e-10,108;CL:0002032,1.66e-08,161;CL:0000837,1.66e-08,161;CL:0000037,3.86e-08,168;CL:0000988,1.04e-07,177 | |||
|ontology_enrichment_development_v019=CL:0002425;2.32e-12;2 | |||
|ontology_enrichment_disease=DOID:1240!1.64e-40!39;DOID:8692!1.16e-38!31;DOID:2531!1.15e-34!51;DOID:0060083!1.15e-34!51;DOID:0050686!1.81e-12!137;DOID:1036!4.21e-09!8;DOID:8552!1.42e-08!1;DOID:162!6.79e-07!235 | |||
|ontology_enrichment_disease_v019=DOID:8692;7.89e-35;31!DOID:1240;3.29e-31;39!DOID:2531;1.22e-18;51!DOID:0060083;1.22e-18;51!DOID:1036;4.54e-12;8 | |||
|ontology_enrichment_disease_v019_2=DOID:1240,7.29e-36,39;DOID:8692,1.24e-34,31;DOID:2531,1.98e-27,51;DOID:0060083,1.98e-27,51;DOID:1036,4.42e-12,8;DOID:0050686,4.90e-10,137;DOID:162,2.69e-07,235;DOID:14566,3.89e-07,239 | |||
|ontology_enrichment_uberon=UBERON:0000998!9.02e-09!1;UBERON:0006868!9.02e-09!1 | |||
|ontology_enrichment_uberon_v019= | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002370,8.14e-07,4;UBERON:0005058,8.14e-07,4;UBERON:0009113,8.14e-07,4;UBERON:0003295,8.14e-07,4;UBERON:0005562,8.14e-07,4 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0764134057479513,0,0.157421562627358,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.371457501329565,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.441463099414651,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.088048434013226,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.5360035353916,0,0,0,0,0,0,0.167516265334349,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.144269212976445,0,0,4.19116680008915,0,24.3424620132465,0,0.280797178113459,38.5716607566095,0,0,0.169291777801603,0,0,0,1.71752672377882,0,0,0,0,25.6133679983623,0,0.540911356951966,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.511572370226872,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,154.311592036309,0.166211681900156,0,0,0,0,0.158936578980379,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.76136620346166,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.27668251554036,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.230467975111559,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.423387050190929,0,0,0,0,0,0,0,0,0,0,0,0,0.118920090777569,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.535928260312357,0,0,0,0,0,0,0.784923038064294,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr8:114747320..114747347,- | |||
}} |
Revision as of 23:25, 22 January 2014
Short description: | p@chr8:114747320..114747347, - |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | No |
DHS support(Yes/No): | No |
Description: | CAGE_peak_at_chr8:114747320..114747347, - |
Coexpression cluster: | C215_chronic_acute_peripheral_Hepatocyte_osteosarcoma_NK_immature |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
innate effector T cell | 2.62e-23 | 1 |
immature NK T cell | 2.62e-23 | 1 |
effector T cell | 2.62e-23 | 1 |
mature NK T cell | 2.62e-23 | 1 |
immature NK T cell stage IV | 2.62e-23 | 1 |
immature NK T cell stage I | 2.62e-23 | 1 |
immature NK T cell stage II | 2.62e-23 | 1 |
immature NK T cell stage III | 2.62e-23 | 1 |
thymocyte | 2.32e-12 | 2 |
double negative thymocyte | 2.32e-12 | 2 |
double-positive, alpha-beta thymocyte | 2.32e-12 | 2 |
DN4 thymocyte | 2.32e-12 | 2 |
DN1 thymic pro-T cell | 2.32e-12 | 2 |
DN2 thymocyte | 2.32e-12 | 2 |
DN3 thymocyte | 2.32e-12 | 2 |
immature single positive thymocyte | 2.32e-12 | 2 |
early T lineage precursor | 2.32e-12 | 2 |
myeloid cell | 8.31e-10 | 108 |
common myeloid progenitor | 8.31e-10 | 108 |
hematopoietic oligopotent progenitor cell | 1.66e-08 | 161 |
hematopoietic multipotent progenitor cell | 1.66e-08 | 161 |
hematopoietic stem cell | 3.86e-08 | 168 |
hematopoietic cell | 1.04e-07 | 177 |
Ontology term | p-value | n |
---|---|---|
thymus | 8.14e-07 | 4 |
hemolymphoid system gland | 8.14e-07 | 4 |
thymic region | 8.14e-07 | 4 |
pharyngeal gland | 8.14e-07 | 4 |
thymus primordium | 8.14e-07 | 4 |
Ontology term | p-value | n |
---|---|---|
leukemia | 7.29e-36 | 39 |
myeloid leukemia | 1.24e-34 | 31 |
hematologic cancer | 1.98e-27 | 51 |
immune system cancer | 1.98e-27 | 51 |
chronic leukemia | 4.42e-12 | 8 |
organ system cancer | 4.90e-10 | 137 |
cancer | 2.69e-07 | 235 |
disease of cellular proliferation | 3.89e-07 | 239 |